01 maj: Tirsdagens aktier: Amerikansk påvirkning gav plusser til sidst
01 maj: Markedsoversigt: Finansmarkedernes hviledag
01-05-2012 17:24:00

UPDATE: DuPont Buys Full Ownership Of Solae Venture From Partner Bunge

Relateret indhold

--DuPont buys Bunge's 28% stake in Solae venture

--DuPont pays Bunge $440 million

--Bunge to invest proceeds in core businesses

(Updates to include financial terms of deal in 1st paragraph, Bunge earnings in the 6th paragraph and comment by CFO in the 7th paragraph)

DOW JONES NEWSWIRES

E.I. DuPont de Nemours & Co. paid Bunge Ltd. (BG) about $440 million to acquire full ownership of Solae LLC, their soy-based ingredients venture, as DuPont looks to expand its position in the food ingredients market.

DuPont previously owned 72% of the venture while Bunge owned the remaining 28%.

The companies formed the venture in early 2003 to produce and distribute specialty food ingredients. At that time, DuPont estimated initial global revenue from Solae to exceed $800 million annually. In exchange for its specialty-food-ingredients businesses in 2003, Bunge was to receive the 28% interest in the venture plus an estimated $260 million, which was funded by joint-venture debt.

DuPont said its long-term segment financial targets are to post a 7% to 9% compound annual growth rate for sales and to expand pretax earnings margins 12% to 14%. With full ownership of Solae, DuPont expects to reach the upper end of its margin targets with planned synergies.

The chemicals giant last month reported its first-quarter profit rose 4% as higher pricing and a jump in sales of agricultural products contributed to a 12% sales increase.

Meanwhile, Bunge reported last week its first-quarter earnings fell by a greater-than-expected 60% as weak prices for fertilizer and its sugar-based ethanol hurt margins, though revenue grew 10%.

The Solae deal allows Bunge "to redeploy capital into our strategic, core businesses," said Chief Financial Officer Drew Burke in a statement Tuesday.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

(END) Dow Jones Newswires

May 01, 2012 11:24 ET (15:24 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Carlsberg: Russisk ølproduktion fortsætter i bakgear

22-05-2015 16:33:25
Carlsberg og de øvrige bryggerier på det russiske ølmarked fortsætter med at holde igen med ølbrygningen i landet. Således faldt ølproduktionen i Rusland med 7,..

Novo: Ny fusion styrker købersiden ved forhandlingsbordet

22-05-2015 14:15:45
Medicinalselskaberne kan formentlig se frem til endnu sværere prisforhandlinger fremover i USA. Modparterne ved forhandlingsbordet, de såkaldte Pharma Benefit M..

Aktier/åbning: Zealand i rødt efter regnskab

22-05-2015 09:18:44
Det danske C20 Cap-indekset starter med bevægelser fra side til side i niveauet 1.016 fredag morgen på en dag, hvor Zealand Pharma - uden for eliteindekset - er..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
MHI Vestas/dir: Succes er kommet langt hurtigere end ventet
2
Novo: Ny fusion styrker købersiden ved forhandlingsbordet
3
Novo: Ingeniørmangel vækker flyttetanker - avis
4
Mærsk nær milliardsalg af Esbjerg-rederi - avis
5
Aktier/åbning: Zealand i rødt efter regnskab

Relaterede aktiekurser

Du Pont (E.I.) de Nemour.. 70,79 -0,3% Fald i aktiekurs
Bunge Ltd 91,22 -0,4% Fald i aktiekurs
DU Pont DE Nemours 63,70 -1,3% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. maj 2015 22:39:50
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150519.1 - EUROWEB3 - 2015-05-22 22:39:50 - 2015-05-22 22:39:50 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x